Pharmacokinetics, Safety and Immunogenicity of RPH-104 at a New Dosage and Different Doses Via Single Subcutaneous and Intravenous Administration in Healthy Volunteers
Clinical trial NCT07206043 · COMPLETED
Trial details
- NCT number
- NCT07206043
- Sponsor
- R-Pharm International, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-03
- Primary completion
- 2025-02-27
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.